CLINICAL RESEARCH: HEART FAILURE
Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionA Community-Based Study
Carolyn S.P. Lam, MBBS*, ,
Véronique L. Roger, MD, MPH*,
Richard J. Rodeheffer, MD*,
Barry A. Borlaug, MD*,
Felicity T. Enders, PhD and
Margaret M. Redfield, MD*,*
* Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
Yong Loo Lin School of Medicine, Singapore, Singapore
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
Manuscript received August 20, 2008;
revised manuscript received November 17, 2008,
accepted November 30, 2008.
* Reprint requests and correspondence: Dr. Margaret M. Redfield, 200 First Street SW, Rochester, Minnesota 55905 (Email: redfield.margaret{at}mayo.edu).
Objectives: This study sought to define the prevalence, severity, and significance of pulmonary hypertension (PH) in heart failure with preserved ejection fraction (HFpEF) in the general community.
Background: Although HFpEF is known to cause PH, its development is highly variable. Community-based data are lacking, and the relative contribution of pulmonary venous versus pulmonary arterial hypertension (HTN) to PH in HFpEF is unknown. We hypothesized that PH would be a marker of symptomatic pulmonary congestion, distinguishing HFpEF from pre-clinical hypertensive heart disease.
Methods: This community-based study of 244 HFpEF patients (age 76 ± 13 years; 45% male) was followed up using Doppler echocardiography over 3 years. Control subjects were 719 adults with HTN without HF (age 66 ± 10 years; 44% male). Pulmonary artery systolic pressure (PASP) was derived from the tricuspid regurgitation velocity and PH defined as PASP >35 mm Hg. Pulmonary capillary wedge pressure (PCWP) was estimated from the ratio of early transmitral flow velocity to early mitral annular diastolic velocity.
Results: In HFpEF, PH was present in 83% and the median (25th, 75th percentile) PASP was 48 (37, 56) mm Hg. PASP increased with PCWP (r = 0.21; p < 0.007). Adjusting for PCWP, PASP was higher in HFpEF than HTN (p < 0.001). The PASP distinguished HFpEF from HTN with an area under the receiver-operating characteristic curve of 0.91 (p < 0.001) and strongly predicted mortality in HFpEF (hazard ratio: 1.3 per 10 mm Hg; p < 0.001).
Conclusions: PH is highly prevalent and often severe in HFpEF. Although pulmonary venous HTN contributes to PH, it does not fully account for the severity of PH in HFpEF, suggesting that a component of pulmonary arterial HTN also contributes. The potent effect of PASP on mortality lends support for therapies aimed at pulmonary arterial HTN in HFpEF.
Key Words: pulmonary hypertension diastolic heart failure heart failure with preserved ejection fraction
|
Abbreviations and Acronyms
| | AUC = area under the curve | | COPD = chronic obstructive pulmonary disease | | EF = ejection fraction | | HF = heart failure | | HFpEF = heart failure with preserved ejection fraction | | HTN = hypertension | | PASP = pulmonary artery systolic pressure | | PCWP = pulmonary capillary wedge pressure | | PH = pulmonary hypertension | | TR = tricuspid regurgitation |
|
Related Articles
-
The Role of the Pulmonary Vasculature in Heart Failure With Preserved Ejection Fraction
- Gregory D. Lewis
J. Am. Coll. Cardiol. 2009 53: 1127-1129.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
C. C. Welles, I. A. Ku, D. M. Kwan, M. A. Whooley, N. B. Schiller, and M. P. Turakhia
Left Atrial Function Predicts Heart Failure Hospitalization in Subjects With Preserved Ejection Fraction and Coronary Heart Disease: Longitudinal Data From the Heart and Soul Study
J. Am. Coll. Cardiol.,
February 14, 2012;
59(7):
673 - 680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Szwejkowski, D. H. J. Elder, F. Shearer, D. Jack, A. M. J. Choy, S. D. Pringle, A. D. Struthers, J. George, and C. C. Lang
Pulmonary hypertension predicts all-cause mortality in patients with heart failure: a retrospective cohort study
Eur J Heart Fail,
February 1, 2012;
14(2):
162 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Schwartzenberg, M. M. Redfield, A. M. From, P. Sorajja, R. A. Nishimura, and B. A. Borlaug
Effects of Vasodilation in Heart Failure With Preserved or Reduced Ejection Fraction: Implications of Distinct Pathophysiologies on Response to Therapy
J. Am. Coll. Cardiol.,
January 31, 2012;
59(5):
442 - 451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Donal, C. Thebault, L. H. Lund, G. Kervio, A. Reynaud, T. Simon, E. Drouet, E. Nonotte, C. Linde, and J.-C. Daubert
Heart failure with a preserved ejection fraction additive value of an exercise stress echocardiography
Eur Heart J Cardiovasc Imaging,
January 29, 2012;
(2012)
jes010v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Bursi, S. M. McNallan, M. M. Redfield, V. T. Nkomo, C. S. P. Lam, S. A. Weston, R. Jiang, and V. L. Roger
Pulmonary Pressures and Death in Heart Failure: A Community Study
J. Am. Coll. Cardiol.,
January 17, 2012;
59(3):
222 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Park and M. R. Mehra
Pulmonary Hypertension: The Great Leveler
J. Am. Coll. Cardiol.,
January 17, 2012;
59(3):
232 - 234.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Zile, J. S. Gottdiener, S. J. Hetzel, J. J. McMurray, M. Komajda, R. McKelvie, C. F. Baicu, B. M. Massie, P. E. Carson, and for the I-PRESERVE Investigators
Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction
Circulation,
December 6, 2011;
124(23):
2491 - 2501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ghoreishi, C. F. Evans, C. R. DeFilippi, G. Hobbs, C. A. Young, B. P. Griffith, and J. S. Gammie
Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: Implications for timing of surgery
J. Thorac. Cardiovasc. Surg.,
December 1, 2011;
142(6):
1439 - 1452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Damy, A. Kallvikbacka-Bennett, J. Zhang, K. Goode, L. Buga, J. Hobkirk, A. Yassin, J.-L. Dubois-Rande, L. Hittinger, J. G. F. Cleland, et al.
Does the physical examination still have a role in patients with suspected heart failure?
Eur J Heart Fail,
December 1, 2011;
13(12):
1340 - 1348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Chatterjee and G. D. Lewis
What Is the Prognostic Significance of Pulmonary Hypertension in Heart Failure?
Circ Heart Fail,
September 1, 2011;
4(5):
541 - 545.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Aronson, A. Eitan, R. Dragu, and A. J. Burger
Relationship Between Reactive Pulmonary Hypertension and Mortality in Patients With Acute Decompensated Heart Failure
Circ Heart Fail,
September 1, 2011;
4(5):
644 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Meluzin, J. Sitar, J. Kristek, R. Prosecky, M. Pesl, H. Podrouzkova, V. Soska, R. Panovsky, and L. Dusek
The role of exercise echocardiography in the diagnostics of heart failure with normal left ventricular ejection fraction
Eur Heart J Cardiovasc Imaging,
August 1, 2011;
12(8):
591 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Waxman
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target for Therapy?
Circulation,
July 12, 2011;
124(2):
133 - 135.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guazzi, M. Vicenzi, R. Arena, and M. D. Guazzi
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study
Circulation,
July 12, 2011;
124(2):
164 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Montani and I. M. Lang
Mast cells: bridging the gap between pre- and post-capillary pulmonary hypertension?
Eur. Respir. J.,
June 1, 2011;
37(6):
1303 - 1305.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hoffmann, J. Yin, M. Kukucka, N. Yin, I. Saarikko, A. Sterner-Kock, H. Fujii, H. Leong-Poi, H. Kuppe, R. T. Schermuly, et al.
Mast cells promote lung vascular remodelling in pulmonary hypertension
Eur. Respir. J.,
June 1, 2011;
37(6):
1400 - 1410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. O. Oghlakian, I. Sipahi, and J. C. Fang
Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm?
Mayo Clin. Proc.,
June 1, 2011;
86(6):
531 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Cole, A. P. Kalogeropoulos, V. V. Georgiopoulou, M. Gheorghiade, A. Quyyumi, C. Yancy, and J. Butler
Hydralazine and Isosorbide Dinitrate in Heart Failure: Historical Perspective, Mechanisms, and Future Directions
Circulation,
May 31, 2011;
123(21):
2414 - 2422.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Borlaug and M. M. Redfield
Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum
Circulation,
May 10, 2011;
123(18):
2006 - 2014.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Borlaug
Discerning Pulmonary Venous From Pulmonary Arterial Hypertension Without the Help of a Catheter
Circ Heart Fail,
May 1, 2011;
4(3):
235 - 237.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Hill, I. Preston, and K. Roberts
Defining the Phenotypes for Pulmonary Hypertension Associated With Diastolic Heart Failure
Circ Heart Fail,
May 1, 2011;
4(3):
238 - 240.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chatterjee
Response to Campbell: Is This a Case of Constriction?
Circ Heart Fail,
May 1, 2011;
4(3):
374 - 377.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Thenappan, S. J. Shah, M. Gomberg-Maitland, B. Collander, A. Vallakati, P. Shroff, and S. Rich
Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction
Circ Heart Fail,
May 1, 2011;
4(3):
257 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Borlaug
Reply
J. Am. Coll. Cardiol.,
March 29, 2011;
57(13):
1499 - 1500.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Borlaug and W. J. Paulus
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Eur. Heart J.,
March 2, 2011;
32(6):
670 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yin, M. Kukucka, J. Hoffmann, A. Sterner-Kock, J. Burhenne, W. E. Haefeli, H. Kuppe, and W. M. Kuebler
Sildenafil Preserves Lung Endothelial Function and Prevents Pulmonary Vascular Remodeling in a Rat Model of Diastolic Heart Failure
Circ Heart Fail,
March 1, 2011;
4(2):
198 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Drazner
The Progression of Hypertensive Heart Disease
Circulation,
January 25, 2011;
123(3):
327 - 334.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. P. Lam, E. Donal, E. Kraigher-Krainer, and R. S. Vasan
Epidemiology and clinical course of heart failure with preserved ejection fraction
Eur J Heart Fail,
January 1, 2011;
13(1):
18 - 28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Pieske
Heart failure with preserved ejection fraction--a growing epidemic or 'The Emperor's New Clothes?'
Eur J Heart Fail,
January 1, 2011;
13(1):
11 - 13.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. Lang, C. Plank, R. Sadushi-Kolici, J. Jakowitsch, W. Klepetko, and G. Maurer
Imaging in Pulmonary Hypertension
J. Am. Coll. Cardiol. Img.,
December 1, 2010;
3(12):
1287 - 1295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-H. Yan, M. Wang, W.-S. Yue, K.-H. Yiu, C.-W. Siu, S. W. L. Lee, C.-P. Lau, and H.-F. Tse
Elevated pulmonary artery systolic pressure in patients with coronary artery disease and left ventricular dyssynchrony
Eur J Heart Fail,
October 1, 2010;
12(10):
1067 - 1075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Maeder, B. R. Thompson, H.-P. Brunner-La Rocca, and D. M. Kaye
Hemodynamic Basis of Exercise Limitation in Patients With Heart Failure and Normal Ejection Fraction
J. Am. Coll. Cardiol.,
September 7, 2010;
56(11):
855 - 863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Borlaug, R. A. Nishimura, P. Sorajja, C. S. P. Lam, and M. M. Redfield
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Circ Heart Fail,
September 1, 2010;
3(5):
588 - 595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. P. Lam
Heart Failure With Preserved Ejection Fraction: Invasive Solution to Diagnostic Confusion?
J. Am. Coll. Cardiol.,
April 20, 2010;
55(16):
1711 - 1712.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kerem, J. Yin, S. M. Kaestle, J. Hoffmann, A. M. Schoene, B. Singh, H. Kuppe, M. M. Borst, and W. M. Kuebler
Lung Endothelial Dysfunction in Congestive Heart Failure: Role of Impaired Ca2+ Signaling and Cytoskeletal Reorganization
Circ. Res.,
April 2, 2010;
106(6):
1103 - 1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D Correa de Sa, D. O Hodge, J. P Slusser, M. M Redfield, R. D Simari, J. C Burnett, and H. H Chen
Progression of preclinical diastolic dysfunction to the development of symptoms
Heart,
April 1, 2010;
96(7):
528 - 532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Paulus and J. J.M. van Ballegoij
Treatment of Heart Failure With Normal Ejection Fraction: An Inconvenient Truth!
J. Am. Coll. Cardiol.,
February 9, 2010;
55(6):
526 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W.-K. Yip, M. Frenneaux, and J. E Sanderson
Heart failure with a normal ejection fraction: new developments
Heart,
October 1, 2009;
95(19):
1549 - 1552.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Guazzi
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: Any Pathophysiological Role of Mitral Regurgitation
J. Am. Coll. Cardiol.,
September 22, 2009;
54(13):
1191 - 1192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S.P. Lam and M. M. Redfield
Reply
J. Am. Coll. Cardiol.,
September 22, 2009;
54(13):
1192 - 1192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Little and J. K. Oh
Echocardiographic Evaluation of Diastolic Function Can Be Used to Guide Clinical Care
Circulation,
September 1, 2009;
120(9):
802 - 809.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tschope and W. J. Paulus
Doppler Echocardiography Yields Dubious Estimates of Left Ventricular Diastolic Pressures
Circulation,
September 1, 2009;
120(9):
810 - 820.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Maeder and D. M. Kaye
Reply
J. Am. Coll. Cardiol.,
July 28, 2009;
54(5):
488 - 489.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. Lewis
The Role of the Pulmonary Vasculature in Heart Failure With Preserved Ejection Fraction
J. Am. Coll. Cardiol.,
March 31, 2009;
53(13):
1127 - 1129.
[Full Text]
[PDF]
|
 |
|
|